Early Phase 1 Pancreatic Cancer Trial, Recruiting (NCT07597772)

Early Phase 1 Pancreatic Cancer Trial, Recruiting NCT07597772 Sponsor: SmartNuclide Biopharma Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07597772 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old (inclusive)
You are able to make your own decisions, are willing to take part voluntarily, and have signed the consent form for the study
You have been diagnosed with pancreatic cancer and your tumour can be tested for a protein called Claudin-18.2
You have results from a stomach camera scan, CT scan, MRI, or PET-CT scan done within the past month (if these are available)
You have pathology (tissue or lab test) results from within the past year

Who may not be able to join:

You have been diagnosed with another type of cancer in addition to pancreatic cancer
You have a severe infection that is not under control, or you have other serious health conditions
Your doctors estimate that you have three months or less to live
You are pregnant, breastfeeding, or are capable of becoming pregnant but are unwilling to use suitable contraception during the trial
The trial doctor has decided, for any reason, that the trial is not appropriate for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 022-23340123

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07597772

Sponsor: SmartNuclide Biopharma

Phase: Early Phase 1

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 022-23340123

More information: https://clinicaltrials.gov/study/NCT07597772

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old (inclusive)
You are able to make your own decisions, are willing to take part voluntarily, and have signed the consent form for the study
You have been diagnosed with pancreatic cancer and your tumour can be tested for a protein called Claudin-18.2
You have results from a stomach camera scan, CT scan, MRI, or PET-CT scan done within the past month (if these are available)
You have pathology (tissue or lab test) results from within the past year

Who may not be able to join:

You have been diagnosed with another type of cancer in addition to pancreatic cancer
You have a severe infection that is not under control, or you have other serious health conditions
Your doctors estimate that you have three months or less to live
You are pregnant, breastfeeding, or are capable of becoming pregnant but are unwilling to use suitable contraception during the trial
The trial doctor has decided, for any reason, that the trial is not appropriate for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

SmartNuclide Biopharma

Registry

ClinicalTrials.gov

Start date

1 October 2025

Est. completion

1 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The safety and tolerability profile of [68Ga]Ga-NODAGA-SNA014 in patients with CLDN18.2-positive pancreatic cancer.; CLDN18.2-targeting ability of [68Ga]Ga-NODAGA-SNA014 in patients with CLDN18.2-positive pancreatic cancer.; CLDN18.2-targeting ability of [68Ga]Ga-NODAGA-SNA014 in patients with CLDN18.2-positive pancreatic cancer.; CLDN18.2-targeting ability of [68Ga]Ga-NODAGA-SNA014 in patients with CLDN18.2-positive pancreatic cancer.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov